Replies to post #917 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

>…might Roche first try a lot lower dose of 1626 before trying another Polymerase?<

Sure—they may end up doing exactly that. The change is that R1626 has up to now been viewed as a shoo-in for combination with 191; now, it’s merely one of the options Roche may pursue.